ProQR Therapeutics (PRQR) FCF Margin (2013 - 2026)
ProQR Therapeutics' FCF Margin was -136.76% in the quarter ended Jun 30, 2026, up 159.28 percentage points from -296.04% a year earlier and up 403.38 percentage points from the prior quarter.
ProQR Therapeutics (PRQR) FCF Margin (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, ProQR Therapeutics' FCF Margin was -261.00% through Jun 30, 2026, down 10.02 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at -325.48%, down 140.48 percentage points from the prior year.
- FCF Margin shows a four-year change of +1586.73 percentage points (years ended Dec 2021 to Dec 2025).
- In earlier years, FCF Margin was -185.00% in the year ended Dec 31, 2024 (-536.85 pp), 351.84% in the year ended Dec 31, 2023 (+2238.32 pp), -1886.48% in the year ended Dec 31, 2022 (+25.73 pp) and -1912.21% in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly FCF Margin since the quarter ended Jun 30, 2024.
- Compared with a year earlier, FCF Margin was higher in two of the last eight quarters, with an average year-over-year change of -35.46 percentage points.
- The best year-over-year quarter for FCF Margin over five years was the quarter ended Mar 31, 2023 (a gain of 8638.65 percentage points); the worst was the quarter ended Mar 31, 2024 (a drop of 7172.60 percentage points).
- Per Business Quant data, PRQR's FCF Margin in the three quarters before the quarter ended Jun 30, 2026 was -540.14% (quarter ended Mar 31, 2026), -273.70% (quarter ended Dec 31, 2025) and -418.67% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | ProQR Therapeutics | 138.02 Mn | -322.63 Mn | - | -143.41% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -143.41% |
| Mar 31, 2026 | -556.27% |
| Dec 31, 2025 | -296.14% |
| Sep 30, 2025 | -430.40% |
| Jun 30, 2025 | -301.34% |
| Mar 31, 2025 | -354.55% |
| Dec 31, 2024 | -220.13% |
| Sep 30, 2024 | -154.64% |
| Jun 30, 2024 | -103.46% |
| Mar 31, 2024 | -356.49% |
| Dec 31, 2023 | -180.39% |
| Sep 30, 2023 | -572.77% |
| Jun 30, 2023 | -883.07% |
| Mar 31, 2023 | 6,807.48% |
| Dec 31, 2022 | -2,475.00% |
| Sep 30, 2022 | -1,917.69% |
| Jun 30, 2022 | -1,620.97% |
| Mar 31, 2022 | -1,832.83% |
| Dec 31, 2021 | 1,489.54% |
| Sep 30, 2021 | -944.04% |
ProQR Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();